Aktana Stock

Life sciences data-fueled insights

Sign up today and learn more about Aktana Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

Founded

2011

Notable Investors

CIBC Innovation Banking

Headquarters

San Francisco CA, US

Total Funding

$69.2M

About Aktana Stock

Aktana helps life science companies get the most out of artificial intelligence (AI) for commercializing their products. The company’s proprietary platform harnesses machine learning algorithms to enable marketing and sales teams to optimize their engagement with prescribing physicians. Aktana supports more than 100 brands and more than half the top 20 pharmaceutical companies worldwide to increase revenue, capitalize on data investments, and drive channel productivity and results. The company’s focus on the life sciences market allows Aktana to understand and incorporate unique market dynamics more deeply than the major AI players. Headquartered in San Francisco, Aktana also has offices in New York, Philadelphia, London, Barcelona, Tokyo, Osaka, and Shanghai.

Investors

CIBC Innovation Banking

VTS, Impartner, GoodData, Aktana, Stratifyd

Leerink Transformation Partners

PatientPop, Aktana

Safeguard Scientifics

MediaMath, Syapse, Aktana

Starfish Ventures

Aktana

Funding History

August 2011$3.0M
May 2012$2.0M
June 2013$5.5M
June 2016$17.6M
September 2018$21.0M
September 2019$20.0M

Management

Chief Executive Officer

David Ehrlich

Chief Customer Officer

James Anderson

Chief Science Officer

Pini Ben-Or

Chief Financial Officer

Colm Callan

Chief Marketing Officer

Clay Hausmann

Chief Technology Officer

Jin Huang

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo